Centene Corporation (CNC) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary indicates challenges with adjusted EPS guidance reduction, Medicaid attrition, and Marketplace business running below breakeven. The Q&A section highlights concerns over market stability, competitive positioning, and lack of clear guidance on Medicaid margins and exchange stability. Despite some positive aspects like improved SG&A ratio and cash flow, the overall sentiment is negative due to significant financial and operational uncertainties, particularly in the Marketplace and Medicaid segments. This is likely to lead to a negative stock price movement in the short term.
Key Financial Performance
Adjusted EPS (Earnings Per Share) Reported at $0.50 for Q3 2025, ahead of expectations. This was driven by Medicaid HBR improvement, a positive retroactive revenue adjustment in Florida, stronger-than-expected net investment income, and a lower effective tax rate.
Medicaid HBR (Health Benefits Ratio) Improved to 93.4% in Q3 2025, better than expected. This included a $150 million positive revenue adjustment in Florida's Children's Medical Services program, of which $90 million was retroactive to Q1 and Q2 2025. Improvement was also due to rate advocacy, program changes, and fraud interventions.
Premium and Service Revenue Reported at $44.9 billion for Q3 2025. No year-over-year comparison provided.
GAAP Loss Per Share Reported at a loss of $13.50 due to a $6.7 billion non-cash goodwill impairment charge. This charge had no impact on statutory capital, cash, or adjusted EPS.
Medicaid Membership Reported at 12.7 million members as of Q3 2025, with slight attrition expected in the coming quarters.
Commercial Segment HBR Reported at 89.9% for Q3 2025, in line with expectations. This included a $2.4 billion forecast change due to marketplace morbidity and medical expense trends.
Medicare Segment HBR Reported at 94.3% for Q3 2025, reflecting typical cost patterns in Medicare Advantage and PDP. Medicare Advantage medical cost trends were elevated but consistent with expectations.
Adjusted SG&A Expense Ratio Improved to 7.0% in Q3 2025 from 8.3% in Q3 2024, driven by growth in PDP revenue and expense leveraging.
Investment and Other Income Increased by $79 million in Q3 2025 compared to Q2 2025, driven by gains and temporarily higher cash balances.
Cash Flow from Operations Reported at $1.4 billion for Q3 2025, primarily driven by net earnings and timing of pass-through payments.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Medicaid HBR improvement: Achieved 150 basis points of sequential improvement in Medicaid HBR, aided by improved revenue from Florida Children's Medical Services contract and fundamental improvements like rate advocacy, program changes, and fraud interventions.
Marketplace membership: Ended the quarter with 5.8 million members, slightly better than expectations. Positioned for 2026 margin expansion with revised rates and additional actions to minimize margin impact.
Medicare Advantage and PDP: Performed in line with expectations. Medicare Advantage is on track for breakeven in 2027, and PDP positioning is strong for 2026.
Medicaid rate adjustments: Finalized 2025 composite rate adjustment to roughly 5.5%, higher than the 5% expected earlier.
Marketplace repricing: Revised rates for 2026 in states covering 95% of current membership, accounting for morbidity, trend, and policy impacts.
SG&A expense ratio: Improved to 7.0% in Q3 from 8.3% last year, driven by leveraging expenses over higher revenues and disciplined management.
Investment income: Stronger than expected in Q3, driven by one-time gains. Flexibility provided in guidance to take investment losses in Q4 for 2026 trajectory improvement.
Medicaid fraud interventions: Progress in New York with termination of a provider group engaged in suspicious billing practices, leading to cost savings.
Medicare dual eligible populations: Launched enhanced integrated duals model across 8 states, aligning with the transition to integrated D-SNPs effective January 1, 2026.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Medicaid Cost Trends: Behavioral health, home health services, and high-cost drugs are driving above-baseline trends, with behavioral health accounting for 50% of the excess costs. Despite some progress, these trends remain a challenge to Medicaid profitability.
Marketplace Medical Costs: Increased medical cost pressure in September and uncertainty around eAPTC expiration could lead to higher utilization and financial strain. An additional $75 million provision was added to account for potential volatility.
Regulatory and Policy Uncertainty: Uncertainty surrounding eAPTC expiration and Medicaid rate adjustments creates challenges in forecasting and financial planning. Congressional decisions on tax credits remain unresolved.
Fraud, Waste, and Abuse: Significant Medicaid cost pressures in states like New York and Florida due to fraud and abuse. While some progress has been made, these issues continue to impact financial performance.
Medicare Cost Trends: Elevated medical cost trends in Medicare Advantage and PDP segments, with some containment through risk corridors. However, these trends remain a concern for long-term profitability.
Goodwill Impairment: A $6.7 billion non-cash goodwill impairment charge was recorded, reflecting a significant write-down of assets and impacting GAAP results.
Investment Income Volatility: Q3 investment income gains are not expected to recur, and potential losses may be harvested in Q4 to improve 2026 income trajectory.
Operational and Strategic Execution: Challenges in achieving Medicaid margin improvement and Medicare breakeven goals by 2027 require ongoing operational adjustments and strategic focus.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Adjusted EPS Forecast for 2025: Centene has increased its adjusted EPS forecast for 2025 to at least $2, up from the previous forecast of $1.75 per share.
Marketplace Business Outlook: Centene expects meaningful margin improvement in its Marketplace business in 2026 due to pricing actions that account for baseline morbidity, trend, eAPTC expiry, and program integrity impacts. The company has priced its products to support year-over-year margin improvement even if eAPTCs expire.
Medicaid Business Projections: Centene expects a 2025 Medicaid composite rate adjustment of roughly 5.5%, up from the previously targeted 5%. The company anticipates maintaining profitability consistent with its 2025 outlook into 2026.
Medicare Segment Outlook: Centene aims for breakeven pretax margin in its Medicare Advantage business by 2027. The company expects margin recovery to take priority over membership growth in 2026.
Investment Income and Tax Rate: Centene may take investment losses in Q4 2025 to improve the trajectory of investment income in 2026. The company also anticipates a higher tax rate in 2026, which will act as a headwind.
Operational Improvements and Margin Expansion: Centene plans to focus on operational improvements, efficiency gains, and margin expansion to drive EPS growth in 2026.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:How does the company ensure it is ahead of trends in the exchanges, and do competitor exits make the pool less stable for 2026?
A:The company observed a slight uptick in utilization in September, primarily outpatient ED, which correlated with national discussions on rate increases for 2026 and eAPTC. They have accounted for volatility in Q4 utilization with a $200 million provision. For 2026, they revised rates based on adjusted 2025 baseline morbidity, trend assumptions, eAPTC expiration, and risk pool shifts. They believe the market remains competitive and that advanced premium tax credits prevent a 'death spiral.'
Q:Can the company quickly reengage people to sign up if tax credits are extended, and what efforts are in place for this?
A:The company is prepared for a multilayered enrollment process, including potential special enrollment periods or extensions. They plan to use additional marketing efforts and broker relationships to reengage members. However, they anticipate some market contraction in 2026, even if eAPTCs are extended, due to program integrity measures and member breakage.
Q:What is the company's view on Medicaid margins and the impact of work rules and program integrity measures?
A:The company expects stable Medicaid margins in 2026, with no significant impact from work requirements as states have delayed implementation to 2027. They anticipate some membership attrition due to program integrity measures but do not see it as a major swing factor. They are focused on rate advocacy and operational improvements to maintain profitability.
Q:What is the company's competitive positioning in the exchanges for 2026 compared to 2025?
A:The company had 55% of its portfolio in low-cost silver positions in 2025, which will decrease to 42% in 2026. This reflects a focus on margin recovery over membership growth. They expect market contraction in the high teens to mid-30s range, depending on various factors.
Q:What are the assumptions for trends in Medicaid, Medicare, and health exchanges for 2026?
A:Medicare trend is expected to continue in the high single digits to low double digits. Marketplace rates include a mid-30s average increase, driven by fundamental trend and risk pool shifts. Medicaid rates are expected to remain stable, with mid-5% rate increases rolling into 2026 and operational improvements offsetting trend pressures.
Q:What is the company's long-term view on the exchange business and its commitment to it?
A:The company remains committed to the exchange business, viewing it as a platform for future growth. They believe in pricing for value and see potential in ICHRA and other innovative product designs. They are optimistic about the administration's interest in driving affordability and stability in the individual market.
Q:What is the company's outlook on Medicaid rate setting and state budgets?
A:The company sees constructive dialogue with states on rate setting, with states incorporating more recent data. They anticipate budget pressures in 2026 but view this as an opportunity to partner with states to optimize programs and manage care. They also see potential for net new program additions in upcoming procurement cycles.
Q:What are the rate mechanics in Florida, and how do they impact Q4 performance?
A:The Florida rate update was retroactive to Q1 and Q2, contributing to a 93.4% HBR in Q3. Sequential improvement is expected in Q4 due to mid-5% rate increases in the 9/1 and 10/1 cohorts, along with favorable November day counts.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing the long-term stability of the exchange market in the absence of eAPTCs, using vague language about potential policy changes and market dynamics. They also did not provide specific details on how they would achieve consistent Medicaid margin improvement beyond 2026, citing uncertainties in state rate setting and program changes.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
ABA service
Children Medical
Florida Children
HBR Florida
HBR improvement
Marketplace
Medicaid cost
Medical Services
New York
PDP result
President Investor
Star
Wakely
baseline morbidity
commitment
cost drug
cost pressure
demand
driver
eAPTCs
engagement
environment
experience
favorability
fraud waste
headwind
health care
income tax
investment income
landscape
lever
margin Medicare
margin improvement
meantime
policy
profitability
provider
result outlook
tax rate
taxpayer
tool
CNC Transcript
Centene Corporation (CNC) Q1 2026 Earnings Call Transcript
Positive4-28
The earnings call reveals strong financial performance with revenue, net income, and EPS all showing significant year-over-year growth. The company also achieved an improved Medical Loss Ratio and operating cash flow. While forward-looking statements carry inherent risks, the absence of negative sentiment in the Q&A and the optimistic financial metrics suggest a positive outlook. Despite the lack of operational updates, strategic initiatives, and return discussions, the strong financial results and efficient cost management support a positive stock price movement prediction.
Centene Corporation (CNC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Neutral3-10
Centene Corporation (CNC) Q4 2025 Earnings Call Transcript
Unknown2-6
The earnings call reveals a mixed sentiment. Positive aspects include increased EPS forecast, margin improvements, and operational focus. However, concerns arise from potential investment losses, higher tax rates, and lack of breakeven in Medicare Advantage by 2026. The Q&A section highlights cautious optimism with some uncertainties, such as Medicaid trends and management's vague responses. Overall, the sentiment is balanced, resulting in a neutral outlook.
Centene Corporation (CNC) Presents at UBS Global Healthcare Conference 2025 Transcript
Neutral11-11
CNC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
